We came across a bullish thesis on Verona Pharma plc (VRNA) on Capital Employed’s Substack by Patients Capital Management. In this article, we will summarize the bulls’ thesis on VRNA. Verona Pharma plc (VRNA)’s share was trading at $91.53 as of 3rd July.
A patient in a clinic, taking a medication dose from a nebulizer to treat a respiratory disease.
Verona Pharma, a UK-based biopharmaceutical company, is advancing a standout therapeutic with its lead asset, Ohtuvayre, poised to...
